Sort   by:  
 Page size 
UnknownCD49d is the strongest flow cytometry-based predictor of overall survival in chronic lymphocytic leukemia.
Not available
S-EPMC4876311 | biostudies-literature
UnknownChlorambucil plus rituximab as front-line therapy for elderly and/or unfit chronic lymphocytic leukemia patients: correlation with biologically-based risk stratification.
Not available
S-EPMC5685238 | biostudies-literature
UnknownDo age, fitness, and concomitant medications influence management and outcomes of patients with CLL treated with ibrutinib?
Not available
S-EPMC8714729 | biostudies-literature
UnknownEphB2 stem-related and EphA2 progression-related miRNA-based networks in progressive stages of CRC evolution: clinical significance and potential miRNA drivers.
Not available
S-EPMC6271583 | biostudies-literature
UnknownCoexisting conditions and concomitant medications do not affect venetoclax management and survival in chronic lymphocytic leukemia.
Not available
S-EPMC9554118 | biostudies-literature
UnknownNarrative Medicine to integrate patients', caregivers' and clinicians' migraine experiences: the DRONE multicentre project.
Not available
S-EPMC8047556 | biostudies-literature
UnknownCOVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus.
Not available
S-EPMC7347048 | biostudies-literature
UnknownSignificance of PD-L1 in Metastatic Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis.
Not available
S-EPMC10918499 | biostudies-literature
UnknownFactors Associated With Severe Gastrointestinal Diagnoses in Children With SARS-CoV-2 Infection or Multisystem Inflammatory Syndrome.
Not available
S-EPMC8689385 | biostudies-literature
UnknownCOVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study.
Not available
S-EPMC8559135 | biostudies-literature
Sort   by:  
 Page size